Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients With Cirrhosis (Study P02569)

NCT00048724 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

631

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C
Cirrhosis

Interventions

BIOLOGICAL: peginterferon alfa-2b (SCH 54031)

Sponsor

Merck Sharp & Dohme LLC